Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and ra...
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
About this item
Full title
Author / Creator
For the UTUC collaboration , UTUC collaboration , Pradere, Benjamin , D’Andrea, David , Schuettfort, Victor M. , Foerster, Beat , Quhal, Fahad , Mori, Keiichiro , Abufaraj, Mohammad , Margulis, Vitaly , Deuker, Marine , Briganti, Alberto , Muilwijk, Tim , Hendricksen, Kees , Lotan, Yair , Karakiewic, Pierre and F.Shariat, Shahrokh
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
The accurate selection of patients who are most likely to benefit from neoadjuvant chemotherapy is an important challenge in oncology. Serum AGR has been found to be associated with oncological outcomes in various malignancies. We assessed the association of pre-therapy serum albumin-to-globulin ratio (AGR) with pathologic response and o...
Alternative Titles
Full title
Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2557675629
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2557675629
Other Identifiers
ISSN
0724-4983
E-ISSN
1433-8726
DOI
10.1007/s00345-020-03479-3
